The global In Vitro Toxicity Testing market size is estimated at 51.7 billion USD with a CAGR of 10.9% during the forecasted period from 2021-2028.
The global In Vitro Toxicity Testing market size is estimated at 51.7 billion USD with a CAGR of 10.9% during the forecasted period from 2021-2028. A scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria is referred to in vitro toxicity testing. It is extensively utilized to detect any lethal chemicals in the early stages of development of novel pharmaceuticals. IN Vitro Toxicity Testing market involves safety evaluation of drugs, cosmetic products, agrochemicals, etc. without using animals as test models. The key factor driving the growth of In Vitro Toxicity Testing market is attributed to ban on animal testing and rise in R&D activities. Moreover, innovations in genomics and advent of novel approaches of 3D cell cultures is significantly influencing the market size. In addition, early detection of lethal substances in initial trials is expected to show lucrative growth opportunities in the market during the forecast period. Also, a rise in focus on drug discovery along with personalized medicines is increasing the demand for in vitro testing. Besides, the outbreak of COVID-19 pandemic has negatively affected the growth of market across various verticals. But in case of In Vitro Toxicity Testing there is need for this technique and is expected show considerable growth rates during the pandemic. On the other hand, factors such as lack of skilled professionals is estimated to limit the growth of this market.
Table of Content